You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Bulk Pharmaceutical API Sources for TRANSDERM-NITRO


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRANSDERM-NITRO

Vendor Vendor Homepage Vendor Sku API Url
Clearsynth ⤷  Get Started Free CS-O-01966 ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free T-002_CERILLIAN ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free T-021_CERILLIAN ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free T-022_CERILLIAN ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS030254238 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: TRANSDERM-NITRO

Last updated: July 29, 2025


Introduction

Transdermal Nitroglycerin (TRANSDERM-NITRO) is a topical delivery system for nitroglycerin, primarily used in the management of angina pectoris by providing sustained nitrate therapy through skin patches. The efficacy and safety of the product depend critically on the quality of the active pharmaceutical ingredient (API), nitroglycerin, used in manufacturing. Ensuring a reliable, high-quality supply chain for bulk nitroglycerin is paramount for pharmaceutical companies aiming to produce transdermal patches with consistent efficacy, stability, and regulatory compliance.

This detailed analysis explores global API suppliers for nitroglycerin, focusing on their manufacturing capabilities, quality standards, regulatory compliance, and strategic advantages. It aims to assist pharmaceutical professionals in sourcing high-purity nitroglycerin to develop or augment TRANSDERM-NITRO formulations.


Overview of Nitroglycerin as API in Transdermal Therapy

Nitroglycerin (glyceryl trinitrate) is a nitrate vasodilator that relaxes vascular smooth muscle, reducing myocardial oxygen demand. In transdermal systems, it requires an API of exceptionally high purity and stability due to the potential decomposition of nitroglycerin and its sensitivity to environmental factors. The API must meet stringent pharmacopoeial standards (USP, EP, JP) and undergo rigorous quality control.

Manufacturers of bulk nitroglycerin supplying the pharmaceutical sector must comply with Good Manufacturing Practices (GMP), armed with robust quality assurance, batch documentation, and stability data. The API's physical-chemical properties, including particle size, purity (>99%), and impurity profile, influence the drug's transdermal absorption and shelf life.


Global API Suppliers for Nitroglycerin

1. Nutritional and Chemical Industry Leaders

A. Brenntag Specialties

  • Overview: Brenntag specializes in chemical distribution, including pharmaceutical-grade nitroglycerin, serving the global market.
  • Capabilities: Offers pharmaceutical-grade nitroglycerin with high purity, complying with USP/EP standards. Provides custom synthesis and formulation assistance.
  • Regulatory Compliance: Holds certifications, including GMP, ISO, and regulatory approvals aligned with major markets.
  • Customer Advantage: Globally integrated supply chain, flexible packaging, technical support.

B. S. ChemiCon

  • Overview: Based in India, ChemiCon supplies bulk nitroglycerin for pharmaceutical manufacturing.
  • Capabilities: Manufactures high-quality API under strict GMP conditions, with extensive experience exporting to North America and Europe.
  • Quality Assurance: In-house analytical labs for impurity profiling; batch-to-batch consistency.
  • Market Reach: Key partner for pharmaceutical companies seeking reliable API sources from Asia.

2. Dedicated API Manufacturers

A. Sud-Cermed S.A.

  • Location: Mexico
  • Experience: Specializes in nitrate APIs, including nitroglycerin, with decades of experience.
  • Standards: GMP-certified, adheres to APIC (American Pharmacists Association) and international standards.
  • Product Range: Offers APIs with detailed impurity profiles suitable for transdermal application.

B. Solara Genomics (Cayman Chemical)

  • Overview: Although primarily biochemical reagents, this company supplies high-grade nitroglycerin for pharmaceutical research and formulations.
  • Relevance: Suitable for early-stage formulations and development.

3. Chemical Giants and Contract Manufacturing Organizations (CMOs)

A. Merck KGaA / MilliporeSigma

  • Role: Actively involved in producing pharmaceutical-grade nitroglycerin for research and production.
  • Quality: Strict GMP standards, extensive documentation, and validation processes.
  • Advantages: Global logistics, advanced quality assurance systems, regulatory support.

B. Wockhardt Limited

  • Location: India
  • Capabilities: GMP-manufactured nitroglycerin APIs supplied globally with attention to impurity specifications.
  • Strategic Position: Cost-effective supplier with a focus on quality and reliable delivery.

C. Sanofi

  • Role: Sanofi's manufacturing units produce nitrate-based APIs, including nitroglycerin, for internal use and external supply.
  • Regulatory Acumen: Meets stringent international standards with consistent quality control.

Emerging Sources and Specialty Suppliers

  • The Chemistry Group (UK): Offers custom synthesis and high-purity APIs, including nitroglycerin, to specialized pharmaceutical projects.
  • Axiom Chemicals (China): Growing presence as a supplier of chemical intermediates, including nitrates, with ISO and GMP accreditation.

Key Considerations in Selecting API Suppliers

  • Regulatory Compliance & Certification: Ensure suppliers possess GMP certification, and evidence of compliance with local and international pharmaceutical standards.
  • Quality Assurance & Impurity Profile: Prioritize suppliers with robust analytical data, low residual impurities, and consistent batch quality.
  • Supply Chain Stability: Evaluate the supplier’s capacity for continuous, large-volume production, and reliable logistics support.
  • Cost & Lead Time: Balance cost-effective procurement with minimal lead times to support manufacturing schedules.
  • Technical Support: Assess availability of technical data, stability information, and potential custom synthesis services.

Challenges in Sourcing Nitroglycerin API

  • Regulatory Variations: Different countries have distinct regulatory requirements, which can complicate import and approval processes.
  • Safety and Handling: Nitroglycerin's sensitive explosive nature necessitates stringent safety protocols during manufacturing, storage, and shipping.
  • Environmental Concerns: Pollution control and waste disposal standards influence manufacturing practices and supplier certification.
  • Market Dynamics: Limited manufacturers, especially those meeting pharmaceutical quality standards, can lead to supply constraints or higher costs.

Strategies for Pharmaceutical Companies

  • Develop relationships with multiple suppliers to mitigate risks.
  • Conduct thorough supplier audits and verify GMP compliance.
  • Establish long-term contracts with favoritized, proven vendors.
  • Incorporate advanced incoming quality control (IQC) measures to ensure API batch consistency.
  • Engage with suppliers early to facilitate regulatory filings and documentation.

Conclusion

The global landscape for bulk nitroglycerin API sources is concentrated among a handful of reputable manufacturers and distributors. Ensuring product quality, regulatory compliance, and a reliable supply chain is crucial for the manufacturing of TRANSDERM-NITRO patches. Companies should prioritize GMP-certified suppliers with proven impurity profiles and robust logistics capabilities, enabling consistent production, regulatory approval, and ultimately, safe and effective patient outcomes.


Key Takeaways

  • Nitroglycerin API quality is crucial for transdermal formulations; sourcing from GMP-certified, reputable suppliers ensures compliance and product safety.
  • Leading sources include Brenntag Specialties, Wockhardt, Merck (MilliporeSigma), and regional manufacturers in India and Mexico, among others.
  • Supplier evaluation should incorporate quality assurance, impurity profiles, supply capacity, and regulatory history.
  • Developing strategic supplier relationships and diversification mitigates risks associated with supply shortages or compliance issues.
  • Continuous monitoring of supplier performance and regulatory updates is essential in maintaining an uninterrupted supply chain for TRANSDERM-NITRO.

FAQs

1. What are the key qualities to look for in a bulk nitroglycerin API supplier?
Suppliers should have GMP certification, strict impurity controls, proven batch-to-batch consistency, robust analytical data, and reliable supply logistics.

2. Are there regional differences in sourcing nitroglycerin API?
Yes. North American and European sources tend to be highly regulated and GMP-compliant, while Asian suppliers offer cost advantages but require thorough validation of quality and regulatory adherence.

3. How does API purity impact the efficacy of transdermal nitroglycerin patches?
Higher purity API minimizes impurity-related skin irritation and stability issues, ensuring consistent drug absorption and therapeutic efficacy.

4. What safety considerations are involved in handling bulk nitroglycerin?
Nitroglycerin is sensitive to shock, heat, and friction. Manufacturing and transportation must follow strict safety protocols, including specialized containers, controlled environments, and trained personnel.

5. How can companies ensure regulatory compliance when sourcing nitroglycerin API internationally?
By verifying supplier certifications, reviewing batch documentation, and validating compliance with local regulatory standards such as USP, EP, or JP monographs, companies can align their supply chain with regulatory expectations.


References

[1] United States Pharmacopeia (USP) – Monograph on Nitroglycerin.
[2] European Pharmacopoeia (EP) – Specifications for Nitroglycerin.
[3] Supply Chain and Quality Control Reports from Brenntag Specialties and other manufacturers.
[4] Regulatory guidelines from FDA, EMA, and PMDA.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.